138 related articles for article (PubMed ID: 24924314)
1. Phase 1 clinical trial of Vesicare™ (solifenacin) in the treatment of urinary incontinence after radical prostatectomy.
Liss MA; Morales B; Skarecky D; Ahlering TE
J Endourol; 2014 Oct; 28(10):1241-5. PubMed ID: 24924314
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, solifenacin succinate versus placebo control, phase 4, multicenter study evaluating urinary continence after robotic assisted radical prostatectomy.
Bianco FJ; Albala DM; Belkoff LH; Miles BJ; Peabody JO; He W; Bradt JS; Haas GP; Ahlering TE
J Urol; 2015 Apr; 193(4):1305-10. PubMed ID: 25281778
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic effect of solifenacin succinate on the recovery from voiding dysfunction after radical prostatectomy in men with clinically localized prostate cancer: a prospective, randomized, controlled study.
Shim M; Kim J; Park S; Choi SK; Lee SM; Huh KO; Song C; Choo MS; Ahn H
Urology; 2015 May; 85(5):1123-1129. PubMed ID: 25746580
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
Wagg A; Wyndaele JJ; Sieber P
Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617
[TBL] [Abstract][Full Text] [Related]
5. Solifenacin for overactive bladder: secondary analysis of data from VENUS based on baseline continence status.
Toglia MR; Ostergard DR; Appell RA; Andoh M; Fakhoury A; Hussain IF
Int Urogynecol J; 2010 Jul; 21(7):847-54. PubMed ID: 20339833
[TBL] [Abstract][Full Text] [Related]
6. Conservative management of urinary incontinence following robot-assisted radical prostatectomy.
Marchioni M; Primiceri G; Castellan P; Schips L; Mantica G; Chapple C; Papalia R; Porpiglia F; Scarpa RM; Esperto F
Minerva Urol Nefrol; 2020 Oct; 72(5):555-562. PubMed ID: 32432436
[TBL] [Abstract][Full Text] [Related]
7. Solifenacin: as effective in mixed urinary incontinence as in urge urinary incontinence.
Kelleher C; Cardozo L; Kobashi K; Lucente V
Int Urogynecol J Pelvic Floor Dysfunct; 2006 Jun; 17(4):382-8. PubMed ID: 16283422
[TBL] [Abstract][Full Text] [Related]
8. Reductions in overactive bladder-related incontinence from pooled analysis of phase III trials evaluating treatment with solifenacin.
Cardozo L; Castro-Diaz D; Gittelman M; Ridder A; Huang M
Int Urogynecol J Pelvic Floor Dysfunct; 2006 Sep; 17(5):512-9. PubMed ID: 16625311
[TBL] [Abstract][Full Text] [Related]
9. Solifenacin in overactive bladder syndrome.
Simpson D; Wagstaff AJ
Drugs Aging; 2005; 22(12):1061-9. PubMed ID: 16363887
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and tolerability of solifenacin succinate with or without previous use of trospium chloride.
Metello J; Nogueira B; Torgal M; Colaço J; Vieira A; Gonçalves V; Retto H
Int Urogynecol J Pelvic Floor Dysfunct; 2007 Sep; 18(9):1021-5. PubMed ID: 17211528
[TBL] [Abstract][Full Text] [Related]
11. Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence.
Staskin DR; Te AE
BJU Int; 2006 Jun; 97(6):1256-61. PubMed ID: 16686722
[TBL] [Abstract][Full Text] [Related]
12. Degree of preservation of the neurovascular bundles during radical prostatectomy and urinary continence 1 year after surgery.
Steineck G; Bjartell A; Hugosson J; Axén E; Carlsson S; Stranne J; Wallerstedt A; Persson J; Wilderäng U; Thorsteinsdottir T; Gustafsson O; Lagerkvist M; Jiborn T; Haglind E; Wiklund P;
Eur Urol; 2015 Mar; 67(3):559-68. PubMed ID: 25457018
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of urinary incontinence, voiding symptoms and quality of life after open and robot-assisted radical prostatectomy.
Geraerts I; Van Poppel H; Devoogdt N; Van Cleynenbreugel B; Joniau S; Van Kampen M
BJU Int; 2013 Nov; 112(7):936-43. PubMed ID: 23937206
[TBL] [Abstract][Full Text] [Related]
14. The preoperative pad test as a predictor of urinary incontinence and quality of life after robot-assisted radical prostatectomy: a prospective, observational, clinical study.
Kurimura Y; Haga N; Yanagida T; Tanji R; Onagi A; Honda R; Matsuoka K; Hoshi S; Hata J; Onoda M; Sato Y; Akaihata H; Kataoka M; Ogawa S; Ishibashi K; Matsubara A; Kojima Y
Int Urol Nephrol; 2020 Jan; 52(1):67-76. PubMed ID: 31571159
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported outcomes and urodynamic findings in men with persistent lower urinary tract symptoms following robot-assisted radical prostatectomy.
MacKenzie KR; Davis J; Harding C; Aning JJ
Neurourol Urodyn; 2019 Jun; 38(5):1353-1362. PubMed ID: 30980415
[TBL] [Abstract][Full Text] [Related]
16. Solifenacin and tolterodine are equally effective in the treatment of overactive bladder symptoms.
Ho CH; Chang TC; Lin HH; Liu SP; Huang KH; Yu HJ
J Formos Med Assoc; 2010 Oct; 109(10):702-8. PubMed ID: 20970066
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of solifenacin in patients with severe symptoms of overactive bladder: a pooled analysis.
Millard RJ; Halaska M
Curr Med Res Opin; 2006 Jan; 22(1):41-8. PubMed ID: 16393429
[TBL] [Abstract][Full Text] [Related]
18. Solifenacin in overactive bladder syndrome: a viewpoint by Scott Serels.
Serels S
Drugs Aging; 2005; 22(12):1070-1. PubMed ID: 16363888
[No Abstract] [Full Text] [Related]
19. Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial.
Haglind E; Carlsson S; Stranne J; Wallerstedt A; Wilderäng U; Thorsteinsdottir T; Lagerkvist M; Damber JE; Bjartell A; Hugosson J; Wiklund P; Steineck G;
Eur Urol; 2015 Aug; 68(2):216-25. PubMed ID: 25770484
[TBL] [Abstract][Full Text] [Related]
20. Solifenacin in overactive bladder: a viewpoint by Hashim Hashim.
Hashim H
Drugs Aging; 2005; 22(12):1070. PubMed ID: 16363889
[No Abstract] [Full Text] [Related]
[Next] [New Search]
